- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ramucirumab (Cyramza)
Total 168 results
-
Shanghai Henlius BiotechTerminatedHealthy Male VolunteersChina
-
National Health Research Institutes, TaiwanChina Medical University Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical... and other collaboratorsNot yet recruitingChemotherapy | Metastatic Gastric Adenocarcinoma | Second Line
-
SCRI Development Innovations, LLCCelgeneCompletedGastroesophageal CancerUnited States
-
Hellenic Cooperative Oncology GroupEli Lilly and Company; Celgene CorporationCompleted
-
ROGER S KERESZTES MDTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Walid Shaib, MDEli Lilly and Company; Hoosier Cancer Research NetworkActive, not recruitingPancreatic CancerUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedGastric Cancer | Non-small Cell Lung Cancer | Colo-rectal CancerChina
-
Eli Lilly and CompanyChildren's Oncology GroupCompletedRecurrent Tumor | Pediatric Solid Tumor | Refractory Tumor | CNS MalignanciesUnited States
-
Institut für Klinische Krebsforschung IKF GmbH...CompletedGastric Adenocarcinoma | Metastatic Adenocarcinoma of the Gastroesophageal JunctionGermany
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaItaly, United States, Spain, China, Korea, Republic of, Taiwan, France, Japan, Germany, Belgium, Austria, Brazil, Czechia, Canada, Poland, United Kingdom, Israel, Australia, Hong Kong, Switzerland
-
Washington University School of MedicineEli Lilly and Company; ImmunityBio, Inc.WithdrawnNSCLC | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Carcinoma
-
Eli Lilly and CompanyCompletedNon-small Cell Lung Cancer MetastaticJapan
-
SanofiActive, not recruitingAdenocarcinoma Gastric | Gastrooesophageal CancerJapan, Belgium, Korea, Republic of, Spain, Russian Federation, Turkey
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedCarcinoma, Transitional Cell | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Biliary Tract Cancer | Adenocarcinoma of the Gastroesophageal JunctionGermany, United States, Spain, United Kingdom, France, Japan
-
Eli Lilly and CompanyAstraZenecaCompletedHepatocellular Carcinoma | Gastric Cancer | Non-Small Cell Lung Cancer | Gastroesophageal Junction AdenocarcinomaUnited States, Spain, Korea, Republic of, Taiwan, Germany, Italy, France, Israel
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingGastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States
-
Washington University School of MedicineEli Lilly and CompanyCompletedGastric Adenocarcinoma | Gastro-esophageal Junction AdenocarcinomaUnited States
-
Washington University School of MedicineEli Lilly and CompanyRecruitingRecurrent Head and Neck Carcinoma | Recurrent Head and Neck Squamous Cell Carcinoma | HNSCC | Recurrent Head and Neck Cancer | Metastatic Head and Neck Cancer | Metastatic Head-and-neck Squamous-cell CarcinomaUnited States
-
Institut für Klinische Krebsforschung IKF GmbH...Eli Lilly and Company; Trium Analysis Online GmbHCompletedSquamous Cell Carcinoma of the EsophagusGermany
-
Federation Francophone de Cancerologie DigestiveEli Lilly and CompanyActive, not recruitingStomach Cancer | Gastric Cancer | Gastroesophageal Junction Adenocarcinoma | Stomach NeoplasmFrance
-
University of ChicagoAbbVieCompleted
-
Liza Villaruz, MDCompleted
-
Eli Lilly and CompanyCompletedGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaItaly, United States, Spain, Ukraine, Germany, Greece, Czechia, Turkey, Belgium, Sweden, Canada
-
Abramson Cancer Center at Penn MedicineRecruitingNon-small Cell Lung CancerUnited States
-
Washington University School of MedicineEli Lilly and CompanyActive, not recruitingHead and Neck Squamous Cell CarcinomaUnited States
-
Eli Lilly and CompanyCompletedMetastatic Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaGermany, Italy, Spain, United States, Hungary, Russian Federation, Poland, Belgium, Netherlands, France, Czechia, Mexico, Argentina, Canada, Denmark, Finland, Israel, Japan, Puerto Rico, United Kingdom
-
ALX Oncology Inc.Eli Lilly and CompanyRecruitingGastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Spain, France, Korea, Republic of, Taiwan, United Kingdom, Japan, Singapore, Belgium, Czechia, Italy
-
Gruppo Oncologico Italiano di Ricerca ClinicaUnknown
-
Eli Lilly and CompanyCompletedSolid TumorsUnited States, Spain, France, Belgium
-
Xiuning LeM.D. Anderson Cancer Center; Eli Lilly and CompanyActive, not recruitingNon Small Cell Lung Cancer | Metastatic Cancer | Advanced Cancer | EGFR Gene MutationUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedA Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)Gastric AdenocarcinomaChina
-
Toray Industries, IncRecruitingGastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States, Japan
-
Arkadiusz Z. Dudek, MDBristol-Myers Squibb; Eli Lilly and Company; HealthPartners Institute Regions...TerminatedMesothelioma, MalignantUnited States
-
Eli Lilly and CompanyCompletedMetastatic Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, Taiwan, Japan
-
Anwaar SaeedBristol-Myers Squibb; Clovis Oncology, Inc.RecruitingEsophagus Cancer, Adenocarcinoma | Stomach Cancer, AdenocarcinomaUnited States
-
Harry H YoonMayo Clinic; Merck Sharp & Dohme LLCRecruitingAdenocarcinoma | Gastric Cancer | GastroEsophageal CancerUnited States
-
Bristol-Myers SquibbWithdrawnStomach Cancer | Gastric Cancer | Cancer of the Stomach | Gastroesophageal JunctionBrazil, Italy, United States, Argentina, Chile, Germany, Spain, Australia, Canada, Portugal, Mexico, Romania, Colombia, Puerto Rico
-
Washington University School of MedicineEli Lilly and CompanyCompletedNSCLC | Non Small Cell Lung Cancer | Non-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteEli Lilly and CompanyActive, not recruitingCarcinoid TumorsUnited States
-
Basilea PharmaceuticaTerminatedGastric AdenocarcinomaSpain, United States, Korea, Republic of, Belgium, Russian Federation, United Kingdom, Italy, France, Turkey, Germany, Poland, Brazil, Australia, Argentina, Chile
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Eli Lilly and Company; Merck Sharp & Dohme LLCRecruitingStage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Bristol-Myers SquibbEli Lilly and Company; Clovis Oncology, Inc.; ExelixisWithdrawnCarcinoma, Non-small Cell Lung CancerNetherlands, Norway, Belgium, Greece, United States, Argentina, Denmark, Mexico, Poland, Romania
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCholangiocarcinoma | Liver and Intrahepatic Bile Duct Carcinoma | Unresectable Gallbladder Carcinoma | Stage III Gallbladder Cancer AJCC v7 | Stage IIIA Gallbladder Cancer AJCC v7 | Stage IIIB Gallbladder Cancer AJCC v7 | Stage IV Gallbladder Cancer AJCC v7 | Stage IVA Gallbladder Cancer AJCC v7 | Stage... and other conditionsUnited States
-
Seagen Inc.Active, not recruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Korea, Republic of, United Kingdom, Taiwan, Canada, Australia
-
Daiichi SankyoAstraZenecaRecruitingGastroesophageal Junction Adenocarcinoma | Gastric Cancer, AdenocarcinomaHong Kong, Korea, Republic of, France, United Kingdom, Spain, China, Ireland, Brazil, Japan, Singapore, Belgium, Israel, Russian Federation, Argentina, Chile, Hungary, Poland, Portugal, Taiwan, Turkey, Ukraine, Germany, Romania, Italy
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedCarcinoma, Non-small Cell LungUnited States, Spain
-
Genprex, Inc.RecruitingNon Small Cell Lung CancerUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Recruiting